United Therapeutics focused on the development and commercialization of unique products.Read more
Actelion is the top competitor of United Therapeutics. Actelion is headquartered in Allschwil, Basel-Country, and was founded in 1997. Actelion competes in the Pharmaceuticals field. Actelion generates 157% the revenue of United Therapeutics.
Gilead is perceived as one of United Therapeutics's biggest rivals. Gilead was founded in Foster City, California} in 1987. Like United Therapeutics, Gilead also operates in the Biotechnology industry. Compared to United Therapeutics, Gilead generates $24.1B more revenue.
United Therapeutics's revenue is the ranked 19th among it's top 10 competitors. The top 10 competitors average 24.8B. Over the last four quarters, United Therapeutics's revenue has grown by 4.7%. Specifically, in Q1 2021's revenue was $379.1M; in Q4 2020, it was $384.9M; in Q3 2020, it was $380.1M; in Q2 2020, United Therapeutics's revenue was $362M.